Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Is there a role for immunosuppression in antiphospholipid syndrome?

Ecem Sevim, Rohan Willis, Doruk Erkan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 426–432.

https://doi.org/10.1182/hematology.2019000073

Published: 2019

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Jennifer A. Woyach

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 476–481.

https://doi.org/10.1182/hematology.2019001321

Published: 2019

Journal Articles

Genomics of aggressive B-cell lymphoma

Allison Rosenthal, Lisa Rimsza

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 69–74.

https://doi.org/10.1182/asheducation-2018.1.69

Published: 2018

Journal Articles

Role of the microenvironment across histological subtypes of NHL

Karin Tarte

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 610–617.

https://doi.org/10.1182/asheducation-2017.1.610

Published: 2017

Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.

https://doi.org/10.1182/asheducation-2017.1.618

Published: 2017

Journal Articles

Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies

Kieron Dunleavy

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 298–303.

https://doi.org/10.1182/asheducation-2017.1.298

Published: 2017

Journal Articles

Cellular immune responses in red blood cell alloimmunization

James C. Zimring, Krystalyn E. Hudson

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 452–456.

https://doi.org/10.1182/asheducation-2016.1.452

Published: 2016

Journal Articles

Cold agglutinin disease

Sigbjørn Berentsen

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 226–231.

https://doi.org/10.1182/asheducation-2016.1.226

Published: 2016

Journal Articles

Management of prolymphocytic leukemia

Claire Dearden

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 361–367.

https://doi.org/10.1182/asheducation-2015.1.361

Published: 2015

Journal Articles

Lymphocytosis, lymphadenopathy: benign or malignant?

Jane N. Winter, LoAnn C. Peterson

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 106–110.

https://doi.org/10.1182/asheducation-2015.1.106

Published: 2015

Journal Articles

Update in large cell lymphoma: understanding the pathology report

Eric D. Hsi

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 605–617.

https://doi.org/10.1182/asheducation-2015.1.605

Published: 2015

Journal Articles

Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC

Steven H. Swerdlow

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 90–99.

https://doi.org/10.1182/asheducation-2014.1.90

Published: 2014

Journal Articles

Indolent lymphoma: follicular lymphoma and the microenvironment—insights from the microscope

Nancy Lee Harris

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 158–162.

https://doi.org/10.1182/asheducation-2014.1.158

Published: 2014

Journal Articles

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas

Barbara Vannata, Emanuele Zucca

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 590–598.

https://doi.org/10.1182/asheducation-2014.1.590

Published: 2014

Journal Articles

Indolent lymphoma: follicular lymphoma and the microenvironment—insights from gene expression profiling

Lisa M. Rimsza, Melba C. Jaramillo

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 163–168.

https://doi.org/10.1182/asheducation-2014.1.163

Published: 2014

Journal Articles

Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis

Davide Rossi

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 113–118.

https://doi.org/10.1182/asheducation-2014.1.113

Published: 2014

Journal Articles

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

Adrian Wiestner

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 125–134.

https://doi.org/10.1182/asheducation-2014.1.125

Published: 2014

Journal Articles

HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options

Amrita Krishnan, John A. Zaia

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 584–589.

https://doi.org/10.1182/asheducation-2014.1.584

Published: 2014

NARROW

Is there a role for immunosuppression in antiphospholipid syndrome?

Indolent lymphomas: pushing the pace with novel agents

Myeloma: next generation immunotherapy

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Genomics of aggressive B-cell lymphoma

Role of the microenvironment across histological subtypes of NHL

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies

Cellular immune responses in red blood cell alloimmunization

Cold agglutinin disease

Management of prolymphocytic leukemia

Lymphocytosis, lymphadenopathy: benign or malignant?

Update in large cell lymphoma: understanding the pathology report

Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC

Indolent lymphoma: follicular lymphoma and the microenvironment—insights from the microscope

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas

Indolent lymphoma: follicular lymphoma and the microenvironment—insights from gene expression profiling

Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only